(Q34115175)

31 July 2017

1 reference

title

Premenstrual syndrome and premenstrual dysphoric disorder. (English)

1 reference

31 July 2017

main subject

premenstrual syndrome

1 reference

Wilhelm H Cronje

1

1 reference

31 July 2017

John W W Studd

series ordinal

2

1 reference

31 July 2017

publication date

1 March 2002

1 reference

Primary Care: Clinics in Office Practice

31 July 2017

published in

1 reference

31 July 2017

volume

29

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

1-12, v

1 reference

Helping women with premenstrual syndrome

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

The Premenstrual Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Persistence of symptoms of premenstrual tension in hysterectomized women.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Prophylactic oophorectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Vitamin B6 in the treatment of the premenstrual syndrome--a review.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: A prospective study of pyridoxine neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

The use of vitamin A in pre-menstrual tension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Is evening primrose oil of value in the treatment of premenstrual syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Dietary calcium and manganese effects on menstrual cycle symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Serum and red cell magnesium levels in patients with premenstrual tension

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Magnesium Supplementation Alleviates Premenstrual Symptoms of Fluid Retention

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

A randomized, placebo-controlled clinical trial on the efficacy of chiropractic therapy on premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Premenstrual symptoms are relieved by massage therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

A clinician's guide to the premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Treatment of premenstrual syndrome by spironolactone: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

The effect of a new sequential oestradiol valerate and levonorgestrel preparation on the bone mineral density of postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Randomized controlled trial of the management of premenstrual syndrome and premenstrual mastalgia using luteal phase-only danazol

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Implantation of pure crystalline pellets of estradiol for conception control

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

A randomised comparison over 8 months of 100 μg and 200 μg twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Estrogen Therapy for Severe Persistent Depressions in Women

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Fluoxetine in the treatment of premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0095-4543%2803%2900070-8

7 January 2021

10.1016/S0095-4543(03)00070-8

Identifiers

DOI

1 reference

31 July 2017

1 reference